Skip to main content

Table 3 Factors associated with compliance during the study

From: Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study

Variables Value Odds ratio 95% CI pvalue (vs reference) pvalue (overall)
Compliance at baseline Low (<80%) 1 Reference   <0.001
High (80% to 100%) 6.91 [5.04, 9.46] <0.001  
Country      <0.001
Length of initial treatment >90 days 1 Reference   0.014
31 to 90 days 0.74 [0.54, 1.03] 0.073  
30 days or fewer 1.42 [0.89, 2.27] 0.14  
Insight into illness at baseline Moderate 1 Reference   <0.001
Low/none 0.33 [0.20, 0.56] <0.001  
Medium 0.94 [0.65, 1.35] 0.73  
High 2.79 [1.87, 4.18] <0.001  
Number of days the patient used day hospital   0.99 [0.98, 0.99]   0.002
Satisfaction with life during study Very satisfied 1 Reference   0.002
Satisfied 0.65 [0.48, 0.88] 0.006  
Neither satisfied nor dissatisfied 0.56 [0.37, 0.83] 0.004  
Dissatisfied 0.39 [0.24, 0.62] <0.001  
Very dissatisfied 0.81 [0.39, 1.67] 0.57  
Impairment in work activities during study Severe 1 Reference   0.007
Moderate 0.91 [0.53, 1.57] 0.75  
Mild 1.15 [0.69, 1.92] 0.59  
No 1.64 [0.92, 2.92] 0.09  
Time of observation Per visit     0.013
  1. CI, confidence interval.